Home/Pipeline/eyonis® LCS

eyonis® LCS

Lung Cancer Screening

CommercialFDA 510(k) ClearedN/A (Diagnostic Device)

Key Facts

Indication

Lung Cancer Screening

Phase

Commercial

Status

FDA 510(k) Cleared

Company

Median Technologies

About Median Technologies

Median Technologies is a dual-platform oncology company that transforms medical images into actionable insights for drug development and patient care. Its core achievements include building a profitable Imaging Lab service business supporting over 220 clinical trials and securing FDA 510(k) clearance for its flagship eyonis® LCS device for lung cancer screening. The company's strategy is to leverage its unique clinical expertise and AI platform to become a leader in AI-powered oncology diagnostics while scaling its high-margin imaging services globally.

View full company profile

Therapeutic Areas

Oncology

Other Lung Cancer Screening Drugs

Drug	Company	Phase	Status
SHIELD LUNG Study	Guardant Health	Registrational	Active